Russell Kathryn, Schleichert Rachel, Baum Bertha, Villacorta Miguel, Hardigan Patrick, Thomas Jacqueline, Weiss Eduardo
*The Woodruff Institute, Naples, Florida; †Skin Institute of South Florida, Coral Springs, Florida; ‡Hollywood Dermatology and Cosmetic Surgery Specialists, Hollywood, Florida; §Dermatology Residency Program, Larkin Community Hospital, Miami, Florida; ‖Nova Southeastern University, College of Osteopathic Medicine, Fort Lauderdale, Florida; ¶NSU/Broward Health Dermatology Residency; Fort Lauderdale, Florida; #Herbert Wertheim College of Medicine, Florida International University, Miami, Florida; **Skin Institute of South Florida, Coral Springs, Florida; ††Miller School of Medicine, University of Miami, Coral Gables, Florida.
Dermatol Surg. 2015 Nov;41(11):1249-56. doi: 10.1097/DSS.0000000000000511.
Cutaneous biopsy sites are often difficult to discern or are frequently misidentified when patients present for the treatment of skin cancers. This frustrating situation can lead to delays in treatment and wrong site surgeries. Current methods aiming to prevent this situation are not perfect.
This study seeks to determine the efficacy of ultraviolet-fluorescent tattoos in facilitating the correct identification of suspected nonmelanoma skin cancer biopsy sites.
In this prospective cohort, 51 shave biopsy sites were tattooed with ultraviolet-fluorescent ink in a series of 31 patients suspected of having a cutaneous malignancy. At the time of follow-up, the ability of the patient and the physician to identify the correct site with and without ultraviolet illumination of the tattoo was recorded. Visibility of the tattoo was graded before and after treatment.
Patients could not positively identify their biopsy site in 35% of cases. In 7% of cases, physicians could not confidently identify the site without the aid of ultraviolet illumination. In conjunction with tattoo illumination, physicians confidently identified the site in 100% of the cases. No adverse events occurred.
Ultraviolet-fluorescent tattoos offer a safe and reliable means of accurately marking cutaneous biopsy sites.
当患者前来治疗皮肤癌时，皮肤活检部位往往难以辨别或经常被误认。这种令人沮丧的情况可能导致治疗延误和手术部位错误。目前旨在预防这种情况的方法并不完美。
本研究旨在确定紫外线荧光纹身对促进正确识别疑似非黑色素瘤皮肤癌活检部位的有效性。
在这个前瞻性队列研究中，对31例疑似皮肤恶性肿瘤患者的51个剃除活检部位用紫外线荧光墨水进行纹身。在随访时，记录患者和医生在有和没有纹身紫外线照射的情况下识别正确部位的能力。在治疗前后对纹身的可见性进行分级。
在35%的病例中，患者无法准确识别其活检部位。在7%的病例中，医生在没有紫外线照射的情况下无法确定部位。结合纹身照射，医生在100%的病例中能够确定部位。未发生不良事件。
紫外线荧光纹身提供了一种安全可靠的方法来准确标记皮肤活检部位。
